Last quarter (Q3 2023), Iradimed's total revenue was $16.50M, an increase of 23.10% from the same quarter last year. In Q3, Iradimed's net income was $5.07M. See Iradimed’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 62.97M	$ 53.30M	$ 41.81M	$ 31.72M	$ 38.52M	$ 30.44M
Cost of Revenue	$ 11.06M	$ 12.02M	$ -9.76M	$ 8.14M	$ 8.82M	$ 7.21M
Gross Profit	$ 51.91M	$ 41.28M	$ 32.05M	$ 23.57M	$ 29.70M	$ 23.23M
Operating Expense	$ 32.78M	$ 25.65M	$ -22.23M	$ 24.33M	$ 21.05M	$ 17.22M
Operating Income	$ 19.13M	$ 15.63M	$ 9.82M	$ -756.09K	$ 8.65M	$ 6.00M
Net Non Operating Interest Income Expense	$ 792.14K	$ 581.85K	$ 18.61K	$ 132.19K	$ 388.80K	$ 238.11K
Other Income Expense	$ -846.60K	$ -553.10K	$ -18.59K	$ 139.21K	$ 7.11K	$ -44.57K
Pretax Income	$ 20.76M	$ 16.18M	$ 9.84M	$ -616.88K	$ 9.04M	$ 6.20M
Tax Provision	$ 4.43M	$ 3.35M	$ 510.82K	$ -1.99M	$ -587.64K	$ -106.14K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 16.33M	$ 12.83M	$ 9.33M	$ 1.37M	$ 9.63M	$ 6.30M
Basic EPS	$ 1.29	$ 1.02	$ 0.76	$ 0.11	$ 0.85	$ 0.59
Diluted EPS	$ 1.29	$ 1.02	$ 0.74	$ 0.11	$ 0.78	$ 0.52
Basic Average Shares	$ 50.35M	$ 12.56M	$ 12.35M	$ 12.12M	$ 11.28M	$ 10.76M
Diluted Average Shares	$ 50.78M	$ 12.64M	$ 12.59M	$ 12.44M	$ 12.28M	$ 12.11M
Dividend Per Share	$ 1.05	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	$ 0.40	$ 0.85	$ 0.54
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 43.84M	$ 37.68M	$ -32.00M	$ 32.47M	$ 29.87M	$ 24.44M
Net Income From Continuing And Discontinued Operation	$ 16.33M	$ 12.83M	$ 9.33M	$ 1.37M	$ 9.63M	$ 6.30M
Normalized Income	$ 9.25M	-	-	$ 1.37M	$ 9.63M	$ 6.34M
Interest Expense	-	-	-	-	-	-
EBIT	$ 20.31M	$ 16.18M	$ 9.84M	$ -756.09K	$ 8.65M	$ 6.00M
EBITDA	$ 20.30M	$ 16.85M	$ 11.24M	$ 582.73K	$ 9.89M	$ 7.11M

Currency in USD

Iradimed Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing